Circulating cytokine balance and activation markers of leucocytes in Q fever

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 120-123

  Capo, C ^a   Amirayan, N ^b   Ghigo, E ^a   Raoult, D ^a   Mege, Jean Louis ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Cytokine antagonists; Cytokines; Inflammatory; Leucocyte markers; Q fever; sCD23

Indexed keywords

CD23 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; FEVER; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MALE; PRIORITY JOURNAL; Q FEVER; SYMPTOMATOLOGY;

ADULT; AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; CYTOKINES; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKOCYTES; MALE; MIDDLE AGED; NEOPTERIN; Q FEVER; RECEPTORS, IGE; SIALOGLYCOPROTEINS; SOLUBILITY; UP-REGULATION;

EID: 0032891134     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00786.x     Document Type: Article

References (16)

1. 1 Raoult D, Marrie T. Q fever. Clin Infect Dis 1995; 20:489-96.
2. 2 Raoult D. Host factors in the severity of Q fever. Ann NY Acad Sci 1990; 590:33-38.
3. 3 Mege JL, Maurin M, Capo C et al. Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism. FEMS Microbiol Rev 1997; 19:209-17.
4. 4 Penttila IA, Harris RJ, Storm P et al. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q J Med 1998; 91:549-60.
5. 5 Izzo AA, Marmion BP. Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated and naturally infected subjects. Clin Exp Immunol 1993; 94:507-15.
6. 6 Capo C, Zugun F, Stein A et al. Upregulation of tumor necrosis factor alpha and interleukin-1β in Q fever endocarditis. Infect Immun 1996; 64:1638-42.
7. 7 Fournier PE, Casalta JP, Habib G et al. Modification of the diagnostic criteria proposed by the Duke endocarditis service to permit improved diagnosis of Q fever endocarditis. Am J Med 1996; 100:629-33.
8. 8 Mege JL, Brunet P, Capo C et al. Non-endotoxinic tumour necrosis factor-α-inducing factors in haemodialysis. Nephrol Dial Transplant 1994; 9:1606-10.
9. 9 Olsson I, Gatanaga T, Gullberg U et al. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw 1993; 4:169-80.
10. 10 Aderka D, Engelmann H, Maor Y et al. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175:323-9.
11. 11 Arend NP, Malyak M, Guthridge CJ et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16:27-55.
12. 12 Conrad DH. Fee RII/CD23: the low affinity receptor for IgE. Annu Rev Immunol 1990; 8:623-45.
13. 13 Armant M, Rubio M, Delespesse G et al. Soluble CD23 directly activates monocyte to contribute to the antigen-independent stimulation of resting T cells. J Immunol 1995; 155:4868-75.
14. 14 Bansal AS, Bruce J, Hogan PG et al. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23. Clin Exp Immunol 1997; 110:92-97.
15. 15 Capo C, Iorgulescu I, Mutillod M et al. Increases in the levels of Coxiella burnetii-specific immunoglobulins G1 and G3 antibodies in acute Q fever and chronic Q fever. Clin Diag Lab Immunol 1998 in press.
16. 16 Capo C, Zaffran Y, Zugun F et al. Production of interleukin-10 and transforming growth factor β by peripheral blood mononuclear cells in Q fever endocarditis. Infect Immun 1996; 64:4143-7.